Navigation Links
Alsius Corporation to Host Fourth Quarter and Year-End 2007 Financial Results Conference Call/Webcast on March 13, 2008
Date:3/6/2008

IRVINE, Calif., March 6 /PRNewswire-FirstCall/ -- Alsius Corporation (Nasdaq: ALUS), the worldwide leader in intravascular patient temperature management therapies, announced it will release its fourth quarter and year-end 2007 financial results on March 13, 2008, following the market close.

A conference call and webcast to review the results will follow the same day at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time). This call will be open to all interested parties live via the conference lines listed below. A live webcast will be available on the Investor Relations section of the company's website http://www.alsius.com at 1:30 p.m. PT (4:30 p.m. ET). Beginning 90 minutes after the conference call concludes, an archived version of the webcast will be available on the site, and a telephone replay of the call will be available via the dial-in numbers listed below.

Date: Thursday, March 13, 2008

Live call: Callers within the U.S. may dial 877-440-5791. International

callers can dial 719-325-4879. No passcode is necessary for the

live call.

Webcast: A webcast will be available live via the Investor Relations

section of the company's website http://www.alsius.com at

1:30 p.m. PT (4:30 p.m. ET). Beginning 90 minutes after the

conference call concludes, an archived version of the webcast

will be available on the site.

Replay: Telephone replay will be available beginning 90 minutes after

the call concludes, from March 13 through March 31, 2008. For

the U.S. and Canada, dial 888-203-1112; conference

identification number 3423016. International callers, dial

719-457-0820; conference identification number 3423016.

About Alsius

Alsius, headquartered in Irvine, CA, is a commercial-stage medical device company that develops, manufactures and sells proprietary products to precisely control patient temperature in hospital critical care settings. Controlling body temperature, through cooling and warming, is becoming the standard of care for patients in select critical conditions and those undergoing a variety of surgical procedures. Alsius markets a comprehensive suite of catheter-based intravascular temperature management products that address the need for effective, accurate, easy-to-use and cost-effective control of body temperature in critical care patients. For more information, visit http://www.alsius.com .


'/>"/>
SOURCE Alsius Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO) With $3.52 Price Target
2. MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call on March 4, 2008
3. Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation
4. Insulet Corporation to Report Fourth Quarter and Full Year 2007 Financial Results on Monday, March 17
5. Pharmion Corporation Announces 2007 Operating Results
6. Verenium Corporation to Present at Piper Jaffray Clean Technology & Renewables Conference
7. VLST Corporation Announces Board and Executive Management Appointments
8. AGA Medical Corporation Receives European CE Mark Approval for the AMPLATZER(R) Duct Occluder II
9. AGA Medical Corporation Responds to Occlutech Statement on the Status of the Ongoing Patent Litigation in Europe
10. LifeCell Corporation Revises Full Year 2007 Preliminary Results and Schedules Fourth Quarter 2007 Financial Results Conference Call; February 27, 2008 at 10:00 a.m. Eastern
11. Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... AskLinkerReports.com has published a report on ... Industry 2016 Market Research Report. From a basic outline of ... are all covered in the report. This report projects investment ... of the Amyloglucosidase industry. ... , , Complete ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... light to control cells — optogenetics — is key to exciting advances in ... the art, spatially patterned light projected via free-space optics stimulates small, transparent organisms ...
(Date:12/8/2016)...  Anaconda BioMed S.L., a pre-clinical stage medical device ... neuro-thrombectomy system for the treatment of Acute Ischemic Stroke ... to join its Scientific Advisory Board (SAB). The SAB ... scientific and clinical experts to Anaconda BioMed S.L., as ... ® to its clinical phase. The SAB is ...
(Date:12/8/2016)... , ... December 08, 2016 , ... This CAST literature ... for biotech crops. The authors focus on the economic effects in countries that are ... of new biotech crops and the resultant risk of low level presence (LLP) puts ...
Breaking Biology Technology:
(Date:12/6/2016)...  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the ... €500.0 million principal amount of its 1.414% senior unsecured notes ... senior unsecured notes due 2026. The closing ... subject to the satisfaction of customary closing conditions.  The notes ... The Company intends to use the net proceeds ...
(Date:12/2/2016)... December 1, 2016 The ... Voice), Future Technology (Iris Recognition System), Vehicle Type ... Global Forecast to 2021", published by MarketsandMarkets, the ... in 2016, and is projected to grow to ... of 14.06%.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:11/29/2016)... BOSTON , Nov. 29, 2016 BioDirection, ... rapid point-of-care products for the objective detection of concussion ... the company has successfully completed a meeting with the ... company,s Tbit™ blood test Pre-Submission Package. During the meeting ... Tbit™ system as a precursor to commencement of a ...
Breaking Biology News(10 mins):